Abcuro

Abcuro

The next generation of T cell targeted bio-therapeutics. Learn more

Launch date
Employees
Market cap
-
Enterprise valuation
AUD958m—1.4b (Dealroom.co estimates Aug 2023.)
Newton Massachusetts (HQ)
Authorizing premium user...